Home
About
Overview
Sharing Data
ORCID
Help
History (3)
Integrated genomic analysis suggests MLL3 is a novel candidate susceptibility gene for familial nasopharyngeal carcinoma.
Robust data: the essential foundation of a revised staging system for pleural mesothelioma.
The pemetrexed/gemcitabine combination in pancreatic cancer.
See All 3 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
The pemetrexed/gemcitabine combination in pancreatic cancer.
The pemetrexed/gemcitabine combination in pancreatic cancer. Cancer. 2002 Aug 15; 95(4 Suppl):928-32.
View in:
PubMed
subject areas
Antimetabolites, Antineoplastic
Antineoplastic Combined Chemotherapy Protocols
Clinical Trials as Topic
Deoxycytidine
Glutamates
Guanine
Humans
Pancreatic Neoplasms
Pemetrexed
Survival Analysis
authors with profiles
Hedy Kindler